1 / 5

In Vitro Diagnostics Quality Control Market Dynamics, Outlook and Specifications Forecasts by 2024

In Vitro Diagnostics Quality Control Market Estimated to grow at a significant CAGR over the future period as the scope and its applications are rising enormously across the globe.<br>

Akashchopda
Download Presentation

In Vitro Diagnostics Quality Control Market Dynamics, Outlook and Specifications Forecasts by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. In Vitro Diagnostics Quality Control Market Dynamics, Outlook and Specifications Forecasts by 2024 “The global In Vitro Diagnostics (IVD) Quality Control Market is anticipated to reach USD 1.13 billion by 2024.” Industry Insights The global In Vitro Diagnostics (IVD) Quality Control Market is anticipated to reach USD 1.13 billion by 2024. The rising number of certified clinical laboratories requires quality control (QC) services to maintain their standards, associated with the increasing acceptance of third party providers of quality control services, to ensure the accurate and reproducible test results, and better outcomes which is anticipated to drive the growth. For the establishment of definite standards of quality, the internal Quality Control (QC) programs and the external QAS (Quality Assurance Schemes) is very important to ensure validity and reliability of the test results obtained by the IVD devices. These programs are essential in confirming the delivery of patient diagnostic outcomes, which are reliable and without errors, such as misdiagnosis because of device-related errors, which can impact the health of the patient. The regulation of these In vitro diagnostics devices are controlled by the respective regulatory bodies, which includes the U.S. FDA (Food and Drug Administration), the International Medical Device Regulators Forum (IMDRF), the European Commission, the Australian Therapeutic Goods Administration (TGA), the Eurasian Economic Union (EEU) and the Brazilian National Health Surveillance Agency (ANVISA). Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-quality-control-market/request-sample

  2. The currently undergoing, extensive R&D related activities beside the introduction of new laws with the aim of improving the efficacy and safety levels of the IVD services are anticipated to drive market growth. For example, in September 2012, a new regulation for IVD devices was published by the European Commission targeted to enhance the transparency, safety and the traceability without constraining innovation. These new regulatory inclusions are anticipated to drive the market growth. Type Insights On the type basis, the IVD quality control market is categorized into quality assurance services quality control (QC), and data management. The QC schemes are appropriate to plasma-based, whole blood-based and serum- based products. In 2016, QC market was one of the largest segments because of the rapidly developing IVD technologies and the existence of numerous internal QC programs for the different features of the IVD device- based procedures of testing Application Insights There are numerous applications of the IVDs, which includes haematology, immunology, coagulation, clinical chemistry, molecular diagnostics and microbiology. Amongst these all, molecular diagnostics is anticipated to be the fastest growing market segment with 4.88% CAGR. The frequent usage of the technologies in the molecular diagnostics, such as gene expression and PCR, high accuracy and specificity are some of the responsible factors associated with its high growth. Browse Full Research Report @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-quality-control-market End-use Insights The hospitals market segment was valued the largest market segment of over 46.0% in 2016 owing to the high application of IVD tests in hospitals and the necessity of obedience with the IVD directives for the product traceability. The home care market segment is anticipated to observe a lucrative progression owing to the persistent increase in the usage devices for point-of-care testing. The rise in adoption of microchip technology which is used to handle fluids in IVD equipment, as well as the enhanced production processes and the miniaturization technology are creating efficient point-of-care devices, which are very less susceptible to errors. Regional Insights

  3. In 2016, largest market share of the IVD quality control market was found to be of North America with revenue of approximately USD over 400.0 million. The existence of a huge number of qualified clinical laboratories, a good distribution network and the rising number of IVD products approvals having assured safety and quality from the regulatory authorities are some of the major driving factors. The Asia Pacific region had the highest CAGR of over 4.8% owing to the rising government efforts for the standardization of the testing procedures of the clinical laboratory to improve accuracy of results. Competitive Market Share Insights Some major key players of the IVD quality control market includes Siemens Healthcare GmbH, Alere, Inc., Roche Diagnostics, Abbott Laboratories, Inc., Qiagen N.V., Hologic, Inc. (Gen-Probe), Bio-Rad Laboratories, Inc., Becton, Dickinson and Company(BD), Quidel Corporation, bioMerieux, Inc., Thermo Fisher Scientific, Inc., Sero AS and Sysmex Corporation. Market Segments IVD Quality Control Market Application Outlook, by Revenue (USD Million, 2013 - 2024) • Clinical Chemistry • Immunochemistry • Hematology • Molecular Diagnostics • Coagulation • Microbiology • Others IVD Quality Control Market Type Outlook, by Revenue (USD Million), 2013 - 2024 • Quality Controls • Plasma-based Controls • Serum-based Controls • Whole Blood-based Controls • Other IVD Quality Controls • Data Management • Quality Assurance Services IVD Quality Control Market End-use Outlook, by Revenue (USD Million), 2013 - 2024 • Home-care • Laboratory

  4. • Hospitals • Others IVD Quality Control Market Regional Outlook, by Revenue (USD Million), 2013 - 2024 • North America • U.S. • Canada • Europe • Germany • UK • Asia Pacific • Japan • China • Latin America • Brazil • MEA • South Africa See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/biotechnology

  5. Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com Global Headquarters Million Insights Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States Phone: 1-408-610-2300 Email: sales@millioninsights.com Asia Pacific Million Insights Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India Phone: 91-20-65300184

More Related